

Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Lead Product(s) : Sevoflurane
Therapeutic Area : Psychiatry/Psychology
Study Phase : Undisclosed
Sponsor : Shanghai Pudong New Area Mental Health Center
Deal Size : Inapplicable
Deal Type : Inapplicable
Sevoflurane for Treatment-Resistant Depression
Details : Sevoflurane is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Depressive Disorder, Treatment-Resistant.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
August 17, 2021
Lead Product(s) : Sevoflurane
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Undisclosed
Sponsor : Shanghai Pudong New Area Mental Health Center
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Sevoflurane
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Study Phase : Phase II
Sponsor : National Institute of Arthritis and Musculoskeletal and Skin Diseases
Deal Size : $1.5 million
Deal Type : Funding
Details : The Phase II SBIR funding will be used to develop a formulation of VPX638 (sevoflurane) and to further characterize the anti-inflammatory and analgesic profile in animal disease models.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Undisclosed
November 11, 2020
Lead Product(s) : Sevoflurane
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Highest Development Status : Phase II
Sponsor : National Institute of Arthritis and Musculoskeletal and Skin Diseases
Deal Size : $1.5 million
Deal Type : Funding

Lead Product(s) : Sevoflurane
Therapeutic Area : Gastroenterology
Study Phase : Phase IV
Sponsor : HK inno.N
Deal Size : Inapplicable
Deal Type : Inapplicable
The Effects of Anesthetic Techniques and Palonosetron Administration on the Incidence of PONV
Details : Sevoflurane is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Postoperative Nausea and Vomiting.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
June 22, 2016
Lead Product(s) : Sevoflurane
Therapeutic Area : Gastroenterology
Highest Development Status : Phase IV
Sponsor : HK inno.N
Deal Size : Inapplicable
Deal Type : Inapplicable

Lead Product(s) : Sevoflurane
Therapeutic Area : Neurology
Study Phase : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Influence of Anesthetic Technique on Acute and Chronic Neuropathic Pain
Details : Sevoflurane is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Acute Pain.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
August 18, 2015
Lead Product(s) : Sevoflurane
Therapeutic Area : Neurology
Highest Development Status : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable

Lead Product(s) : Sevoflurane
Therapeutic Area : Urology
Study Phase : Undisclosed
Sponsor : Canadian Urological Association
Deal Size : Inapplicable
Deal Type : Inapplicable
Caudal vs Local Anesthesia in Hypospadias
Details : Sevoflurane is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Hypospadias.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
July 31, 2015
Lead Product(s) : Sevoflurane
Therapeutic Area : Urology
Highest Development Status : Undisclosed
Sponsor : Canadian Urological Association
Deal Size : Inapplicable
Deal Type : Inapplicable

Lead Product(s) : Sevoflurane
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Cardioprotection by Sevoflurane Preconditioning in Noncardiac Thoracic Surgery
Details : Sevoflurane is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
August 15, 2014
Lead Product(s) : Sevoflurane
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable

Lead Product(s) : Sevoflurane
Therapeutic Area : Undisclosed
Study Phase : Phase IV
Sponsor : First Affiliated Hospital, Sun Yat-Sen University | Third Affiliated Hospital, Sun Yat-sen University | Huaqiao Hospital in Guangzhou, China | First People's Hospital of Foshan | Nanfang Hospital, Southern Medical University | Guangdong Provincial People'
Deal Size : Inapplicable
Deal Type : Inapplicable
Comparison of Intravenous Anesthetics to Volatile Anesthetics on Postoperative Cognitive Dysfunction
Details : Sevoflurane is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
March 12, 2013
Lead Product(s) : Sevoflurane
Therapeutic Area : Undisclosed
Highest Development Status : Phase IV
Sponsor : First Affiliated Hospital, Sun Yat-Sen University | Third Affiliated Hospital, Sun Yat-sen University | Huaqiao Hospital in Guangzhou, China | First People's Hospital of Foshan | Nanfang Hospital, Southern Medical University | Guangdong Provincial People'
Deal Size : Inapplicable
Deal Type : Inapplicable

Lead Product(s) : Sevoflurane
Therapeutic Area : Musculoskeletal
Study Phase : Phase IV
Sponsor : Baxter Healthcare Corporation
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Sevoflurane is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Neuromuscular Blockade.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
September 10, 2010
Lead Product(s) : Sevoflurane
Therapeutic Area : Musculoskeletal
Highest Development Status : Phase IV
Sponsor : Baxter Healthcare Corporation
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Sevoflurane
Therapeutic Area : Undisclosed
Study Phase : Phase IV
Sponsor : Rundo International Pharmaceutical Research & Development
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Sevoflurane is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
August 30, 2010
Lead Product(s) : Sevoflurane
Therapeutic Area : Undisclosed
Highest Development Status : Phase IV
Sponsor : Rundo International Pharmaceutical Research & Development
Deal Size : Inapplicable
Deal Type : Inapplicable

Lead Product(s) : Sevoflurane
Therapeutic Area : Neurology
Study Phase : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Physiological Effects of Nitrous Oxide on Anaesthesia
Details : Sevoflurane is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Anesthesia.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
March 25, 2010
Lead Product(s) : Sevoflurane
Therapeutic Area : Neurology
Highest Development Status : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
